Pharmaceutical compositions
US4810497A · kind A · utility
20Cited by
0References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 22, 1988 |
| Grant date | Mar 7, 1989 |
| Priority date | — |
| Expiry date | Jan 22, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Presenile and senile dementia, in particular Alzheimer's disease, can be combated or alleviated by administration of an effective amount of a physiologically acceptable lithium compound and an essential fatty acid or a physiologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.